Conditional Fibroblast BCL-2 Expression Promotes Persistent Pulmonary Fibrosis, which is Reversible by Therapeutic BCL-2 Inhibition
RNA-seq (gene expression) · mouse · 20 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 20 samples: 5 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 InhibitionNature communications · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE307983_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1327920 and SRA study SRP619846. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 20 samples.
How we read this: 5 replicated groups read from 20 sample titles; they account for 20 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9234883 Naïve Rep 1 Naïve
- GSM9234884 Naïve Rep 2 Naïve
- GSM9234885 Naïve Rep 3 Naïve
- GSM9234886 Naïve Rep 4 Naïve
- GSM9234887 3wk Bleo hBcl CO Rep 1 3wk Bleo hBcl CO
- GSM9234888 3wk Bleo hBcl CO Rep 2 3wk Bleo hBcl CO
- GSM9234889 3wk Bleo hBcl CO Rep 3 3wk Bleo hBcl CO
- GSM9234890 3wk Bleo hBcl CO Rep 4 3wk Bleo hBcl CO
- GSM9234891 3wk Bleo hBcl Tamox Rep 1 3wk Bleo hBcl Tamox
- GSM9234892 3wk Bleo hBcl Tamox Rep 2 3wk Bleo hBcl Tamox
- GSM9234893 3wk Bleo hBcl Tamox Rep 3 3wk Bleo hBcl Tamox
- GSM9234894 3wk Bleo hBcl Tamox Rep 4 3wk Bleo hBcl Tamox
- GSM9234895 6wk Bleo hBcl CO Rep 1 6wk Bleo hBcl CO
- GSM9234896 6wk Bleo hBcl CO Rep 2 6wk Bleo hBcl CO
- GSM9234897 6wk Bleo hBcl CO Rep 3 6wk Bleo hBcl CO
- GSM9234898 6wk Bleo hBcl CO Rep 4 6wk Bleo hBcl CO
- GSM9234899 6wk Bleo hBcl Tamox Rep 1 6wk Bleo hBcl Tamox
- GSM9234900 6wk Bleo hBcl Tamox Rep 2 6wk Bleo hBcl Tamox
- GSM9234901 6wk Bleo hBcl Tamox Rep 3 6wk Bleo hBcl Tamox
- GSM9234902 6wk Bleo hBcl Tamox Rep 4 6wk Bleo hBcl Tamox
- GSE182731 Inhibition of ATM in Mouse-derived lung fibroblasts 27 samples shares fibroblast, inhibition
- GSE307419 Pulmonary fibroblast subsets demonstrate differentially enriched signaling pathways during fibrosis resolution and repair 26 samples shares fibroblast, pulmonary
- GSE303692 A plastic EMP1⁺ to LGR5⁺ cell state conversion as a therapeutic bypass to KRAS-G12D inhibition in metastatic colorectal cancer [RNA-Seq] 24 samples shares therapeutic, inhibition
- GSE262420 Mechanomemory of pulmonary fibroblasts demonstrates reversibility of transcriptomics and contraction phenotypes 20 samples shares fibroblast, pulmonary
- GSE269680 CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRASG12D inhibition in pancreatic ductal adenocarcinoma (spatial) 15 samples shares therapeutic, inhibition
- GSE308848 Targeting AEBP1 to mitigate pro-tumor activity of cancer-associated fibroblasts and increase therapeutic efficacy to anti-PD-1 [scRNA-Seq] 12 samples shares therapeutic, fibroblast
- GSE312968 Reversible Fibroblast Trajectories Regulated by MR Underlie Diastolic Dysfunction 12 samples shares fibroblast, reversible
- GSE229815 Transcriptional profiling of 12 month striatum and cortex from a mouse model of Huntington's disease (Q140) crossed with Msh2 heterozygous or homozygous conditional knockout mice [Msh2_12mon] 138 samples shares conditional
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.